Dye laser treatment in proliferative diabetic retinopathy and maculopathy
Authors:
- 1 August 1995
- journal article
- clinical trial
- Published by Wiley in Acta Ophthalmologica Scandinavica
- Vol. 73 (4) , 303-307
Abstract
The aim of this study was to compare the efficacy of various dye laser wavelengths in different forms of retinopathies. The study material consisted of 292 eyes of 210 diabetic retinopathy patients treated with dye laser photocoagulation between 1990 and 1992. All the patients were followed for at least 6 months after photocoagulation. Non-proliferative changes (maculopathy and/or preproliferative retinopathy) were present in 135 (46.3%) and proliferative retinopathy in 157 (53.7%) of the eyes undergoing photocoagulation. Of the 157 eyes with proliferative retinopathy, 60 (20.5%) had disc neovascularization, 71 (24.3%) had retinal neovascularization and 26 (8.9%) had retinitis proliferans. Yellow dye laser (580 nm) was applied in 92 (31.5%) eyes, red dye laser (630 nm) in 120 (41.1%) eyes and both yellow and red dye lasers in 80 (27.4%) eyes. There was no significant difference between the different wavelength groups with regard to visual acuity changes before and after treatment (p < 0.01). Overall, the visual acuity was maintained in 56.2% and improved in 25.0% of the eyes. After panretinal photocoagulation, disc neovascularization regressed partially or completely in 47 (78.3%) of the eyes. There was no significant difference among the various laser wavelengths with regard to treatment efficacy judged by the disappearance or regression of disc neovascularization (p < 0.01). All retinal neovascularizations regressed completely with laser treatment, but in 7 eyes (9.9%) new retinal neovascularizations in previously untreated areas developed. Dye laser has not resulted in any complications. It requires lower power settings compared to argon laser and thus facilitates photocoagulation. Another advantage of dye laser is the ability to use yellow and red wavelengths sequentially.Keywords
This publication has 11 references indexed in Scilit:
- Diode versus argon-green laser panretinal photocoagulation in proliferative diabetic retinopathy: A randomized study in 44 eyes with a long follow-up timeGraefe's Archive for Clinical and Experimental Ophthalmology, 1993
- Does Wavelength Matter When Photocoagulating Eyes With Macular Degeneration or Diabetic Retinopathy?Archives of Ophthalmology (1950), 1993
- Argon Green (514 nm) versus Krypton Red (647 nm) Modified Grid Laser Photocoagulation for Diffuse Diabetic Macular EdemaOphthalmology, 1990
- Clinicopathologic Study of Organic DyeOphthalmology, 1989
- TUNABLE DYE LASER PHOTOCOAGULATION FOR CHOROIDAL NEOVASCULARIZATION COMPLICATING AGE-RELATED MACULAR DEGENERATIONRetina, 1989
- Histopathology of the Effects of Tuneable Dye Laser on Monkey RetinaOphthalmology, 1988
- Clinical Applications of the Organic Dye LaserOphthalmology, 1985
- The Effects of Red Krypton and Green Argon Laser on the Foveal RegionOphthalmology, 1983
- A comparative study of argon laser and krypton laser in the treatment of diabetic optic disc neovascularisation.British Journal of Ophthalmology, 1979
- Tunable Lasers in OphthalmologyOphthalmologica, 1975